Physician profile
Rosario R Augustin
NPI 1356684658
$9,118.50
in general payments reported to CMS, 2019-2025
14 companies · $2,825 in 2025
The $2,825 reported for 2025 was more than what 99% of Psychiatric/Mental Health, Adult (Registered Nurse) providers received nationally (typical 2025 total: $121).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,525 · 2022: $1,148 · 2023: $1,221 · 2024: $2,399 · 2025: $2,825.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,445.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,445.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,599.16 | 2021-2025 | |
| Alkermes, INC. | $1,745.98 | 2021-2025 | Lybalvi, Aristada, Aristada Initio |
| Neurocrine Biosciences, INC. | $1,254.61 | 2021-2025 | Ingrezza |
| Teva Pharmaceuticals USA, INC. | $783.66 | 2022-2025 | Uzedy, Austedo Xr, Austedo Xr |
| Otsuka America Pharmaceutical, INC. | $707.17 | 2021-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| E.R. Squibb & Sons, L.L.C. | $451.88 | 2024-2025 | Cobenfy |
| Janssen Pharmaceuticals, INC | $440.18 | 2023-2024 | Invega Sustenna, Invega Trinza |
| Axsome Therapeutics, INC. | $360.95 | 2024-2025 | Auvelity |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $207.86 | 2024-2025 | Caplyta |
| Sunovion Pharmaceuticals INC. | $152.31 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $145.37 | 2025 | Fanapt |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $136.59 | 2025 | Rejoyn |
| Lundbeck LLC | $108.67 | 2021-2025 | Rexulti |
| Allergan, INC. | $24.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rosario Augustin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.